Form D · Biotechnology

Native Cardio, Inc.

Naples, FL · CIK 0001767312

Offering snapshot reported Mar 5, 2025 · SEC filing

Reported sold
$150K
Offering amount: $1M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 25, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 5, 2025Initial$150,000No comparison1SEC filing
Mar 1, 2023Amendment$465,000$395,000vs May 11, 20217SEC filing
May 11, 2021Initial$70,000No comparison2SEC filing
Jan 26, 2021Amendment$2,500,241$350,140vs Jan 29, 20205SEC filing
Jan 29, 2020Amendment$2,150,101$150,145vs Feb 12, 20194SEC filing
Feb 12, 2019Initial$1,999,956No comparison2SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-539885
SAFE (Simple Agreement for Future Equity)

Source: Form D, filed Mar 5, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christine Mikail Cvijic Director
Myles P. Dempsey, Sr. Director
Gary Dixon Executive
Pedro Granadillo Director
Young D. Kim Director
Joseph V. Pergolizzi Director, Executive
Joseph V. Pergolizzi, Jr. Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
868 106 Th Avenue N Suite 8
Naples, FL, 34108